Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Undergraduate | 2 | 2014 | 160 | 0.780 |
Why?
|
| Methotrexate | 19 | 1985 | 249 | 0.520 |
Why?
|
| Life Change Events | 1 | 2013 | 48 | 0.470 |
Why?
|
| Physical Examination | 1 | 2014 | 149 | 0.470 |
Why?
|
| Job Satisfaction | 1 | 2013 | 73 | 0.460 |
Why?
|
| Clinical Clerkship | 1 | 2014 | 116 | 0.450 |
Why?
|
| Training Support | 2 | 2012 | 23 | 0.450 |
Why?
|
| Science | 1 | 2012 | 34 | 0.430 |
Why?
|
| Diffusion of Innovation | 1 | 2012 | 71 | 0.430 |
Why?
|
| Research Support as Topic | 1 | 2012 | 80 | 0.420 |
Why?
|
| Financing, Personal | 1 | 2012 | 21 | 0.420 |
Why?
|
| Physician's Role | 1 | 2012 | 179 | 0.380 |
Why?
|
| Curriculum | 1 | 2014 | 539 | 0.370 |
Why?
|
| Students, Medical | 1 | 2013 | 384 | 0.330 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2001 | 19 | 0.320 |
Why?
|
| Professional Practice | 1 | 2008 | 46 | 0.310 |
Why?
|
| Environmental Monitoring | 1 | 2005 | 71 | 0.260 |
Why?
|
| beta-Thalassemia | 1 | 2004 | 6 | 0.260 |
Why?
|
| Hemoglobin C Disease | 1 | 2004 | 5 | 0.260 |
Why?
|
| Pediatrics | 3 | 2001 | 344 | 0.250 |
Why?
|
| Air Pollution | 1 | 2005 | 68 | 0.250 |
Why?
|
| Air Pollutants | 1 | 2005 | 78 | 0.240 |
Why?
|
| Central Nervous System Diseases | 1 | 2003 | 52 | 0.230 |
Why?
|
| Erythrocytes | 1 | 2004 | 255 | 0.230 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 8 | 1985 | 32 | 0.230 |
Why?
|
| Environmental Exposure | 1 | 2005 | 296 | 0.220 |
Why?
|
| Osteosarcoma | 6 | 1985 | 158 | 0.220 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 610 | 0.210 |
Why?
|
| Leukemia | 1 | 2003 | 320 | 0.200 |
Why?
|
| Career Choice | 2 | 2001 | 139 | 0.200 |
Why?
|
| Employment | 1 | 2001 | 52 | 0.200 |
Why?
|
| Hemoglobins | 1 | 2001 | 179 | 0.190 |
Why?
|
| Forecasting | 2 | 2008 | 304 | 0.160 |
Why?
|
| Blood Cell Count | 2 | 1996 | 79 | 0.150 |
Why?
|
| Bone Neoplasms | 5 | 1985 | 322 | 0.140 |
Why?
|
| Leucovorin | 6 | 1985 | 218 | 0.140 |
Why?
|
| Humans | 38 | 2014 | 86643 | 0.140 |
Why?
|
| Education, Medical | 2 | 2013 | 233 | 0.130 |
Why?
|
| Apnea | 1 | 1995 | 29 | 0.130 |
Why?
|
| Child Behavior | 1 | 1995 | 48 | 0.130 |
Why?
|
| Leukemia L1210 | 3 | 1980 | 12 | 0.110 |
Why?
|
| Thymidine | 2 | 1983 | 59 | 0.100 |
Why?
|
| Brain | 6 | 1978 | 2216 | 0.100 |
Why?
|
| Lymphoma | 3 | 1981 | 262 | 0.100 |
Why?
|
| Kinetics | 12 | 1983 | 1513 | 0.100 |
Why?
|
| HeLa Cells | 6 | 1974 | 498 | 0.090 |
Why?
|
| United States | 6 | 2005 | 6672 | 0.090 |
Why?
|
| Physicians, Women | 1 | 1990 | 53 | 0.090 |
Why?
|
| Pteridines | 2 | 1978 | 5 | 0.080 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 24 | 0.080 |
Why?
|
| Antineoplastic Agents | 4 | 1981 | 2360 | 0.080 |
Why?
|
| Child | 8 | 2004 | 6927 | 0.080 |
Why?
|
| RNA, Neoplasm | 4 | 1977 | 87 | 0.070 |
Why?
|
| Folic Acid Antagonists | 3 | 1980 | 19 | 0.070 |
Why?
|
| RNA | 6 | 1979 | 560 | 0.070 |
Why?
|
| United States Environmental Protection Agency | 1 | 2005 | 5 | 0.070 |
Why?
|
| Absenteeism | 1 | 2005 | 9 | 0.070 |
Why?
|
| Particle Size | 1 | 2005 | 122 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 1981 | 763 | 0.070 |
Why?
|
| Hemoglobin A2 | 1 | 2004 | 2 | 0.060 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2004 | 15 | 0.060 |
Why?
|
| Homozygote | 1 | 2004 | 200 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 315 | 0.060 |
Why?
|
| Abelson murine leukemia virus | 1 | 2003 | 3 | 0.060 |
Why?
|
| Formates | 1 | 1983 | 6 | 0.060 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1983 | 35 | 0.060 |
Why?
|
| Pneumonia | 1 | 2005 | 179 | 0.060 |
Why?
|
| Mice | 13 | 2003 | 11352 | 0.060 |
Why?
|
| Carboxypeptidases | 2 | 1981 | 35 | 0.050 |
Why?
|
| Male | 12 | 2012 | 40965 | 0.050 |
Why?
|
| Infant | 4 | 2000 | 3046 | 0.050 |
Why?
|
| Health Care Coalitions | 1 | 2002 | 9 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 247 | 0.050 |
Why?
|
| Female | 11 | 2012 | 44532 | 0.050 |
Why?
|
| Total Quality Management | 1 | 2002 | 34 | 0.050 |
Why?
|
| Animals | 20 | 2003 | 26582 | 0.050 |
Why?
|
| Blood Platelets | 2 | 1979 | 149 | 0.050 |
Why?
|
| Safety Management | 1 | 2002 | 56 | 0.050 |
Why?
|
| Directories as Topic | 1 | 2001 | 1 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 1565 | 0.050 |
Why?
|
| Thalassemia | 1 | 2001 | 16 | 0.050 |
Why?
|
| Thymus Gland | 3 | 1971 | 195 | 0.050 |
Why?
|
| Extremities | 2 | 1985 | 167 | 0.050 |
Why?
|
| Pyrimethamine | 1 | 1980 | 21 | 0.050 |
Why?
|
| Thymine Nucleotides | 1 | 1980 | 6 | 0.050 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 1980 | 5 | 0.050 |
Why?
|
| Medical Errors | 1 | 2002 | 115 | 0.050 |
Why?
|
| Cell Line | 9 | 1985 | 2468 | 0.050 |
Why?
|
| Iron | 1 | 2001 | 164 | 0.050 |
Why?
|
| Leadership | 1 | 2002 | 134 | 0.050 |
Why?
|
| RNA, Messenger | 6 | 1977 | 1981 | 0.040 |
Why?
|
| Leukemia, Experimental | 3 | 1985 | 15 | 0.040 |
Why?
|
| Dihydropteridine Reductase | 1 | 1979 | 1 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1979 | 10 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 1983 | 418 | 0.040 |
Why?
|
| Interphase | 1 | 1978 | 34 | 0.040 |
Why?
|
| Internet | 1 | 2001 | 312 | 0.040 |
Why?
|
| Drug Therapy, Combination | 4 | 1983 | 894 | 0.040 |
Why?
|
| Rosette Formation | 1 | 1978 | 34 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 4 | 1982 | 72 | 0.040 |
Why?
|
| Ascitic Fluid | 1 | 1978 | 37 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2232 | 0.040 |
Why?
|
| RNA, Ribosomal | 5 | 1977 | 60 | 0.040 |
Why?
|
| Drug Resistance | 4 | 1984 | 256 | 0.040 |
Why?
|
| Amygdalin | 1 | 1977 | 3 | 0.040 |
Why?
|
| Asthma | 1 | 2005 | 955 | 0.040 |
Why?
|
| Time Factors | 9 | 1983 | 5210 | 0.040 |
Why?
|
| Nitriles | 1 | 1977 | 149 | 0.040 |
Why?
|
| Rabbits | 4 | 1978 | 636 | 0.040 |
Why?
|
| Neutrophils | 1 | 1978 | 307 | 0.040 |
Why?
|
| Reticulocyte Count | 1 | 1996 | 2 | 0.040 |
Why?
|
| Thrombocytosis | 1 | 1996 | 8 | 0.040 |
Why?
|
| Anemia, Macrocytic | 1 | 1996 | 5 | 0.040 |
Why?
|
| Anemia, Neonatal | 1 | 1996 | 5 | 0.040 |
Why?
|
| Kidney | 4 | 1971 | 1241 | 0.040 |
Why?
|
| Cell Cycle | 1 | 1978 | 502 | 0.040 |
Why?
|
| Platelet Count | 1 | 1996 | 92 | 0.040 |
Why?
|
| Melanoma | 1 | 1980 | 459 | 0.040 |
Why?
|
| Cell Nucleus | 5 | 1975 | 579 | 0.030 |
Why?
|
| Doxorubicin | 5 | 1985 | 295 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1980 | 546 | 0.030 |
Why?
|
| Tritium | 6 | 1975 | 133 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2000 | 3612 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1996 | 183 | 0.030 |
Why?
|
| DNA | 3 | 1984 | 1294 | 0.030 |
Why?
|
| Mechlorethamine | 1 | 1974 | 11 | 0.030 |
Why?
|
| Nitrosourea Compounds | 1 | 1974 | 9 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 1974 | 32 | 0.030 |
Why?
|
| Carmustine | 1 | 1974 | 70 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 1996 | 2379 | 0.030 |
Why?
|
| Ribonucleosides | 1 | 1973 | 25 | 0.030 |
Why?
|
| Cell Nucleolus | 4 | 1974 | 23 | 0.030 |
Why?
|
| Cell Division | 4 | 1979 | 696 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 1977 | 265 | 0.030 |
Why?
|
| Respiration | 1 | 1995 | 262 | 0.030 |
Why?
|
| Camptothecin | 2 | 1973 | 189 | 0.030 |
Why?
|
| Cytidine | 1 | 1972 | 17 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1983 | 1961 | 0.030 |
Why?
|
| Alkaloids | 1 | 1972 | 45 | 0.030 |
Why?
|
| Microscopy, Electron | 5 | 1971 | 503 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1977 | 427 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 1974 | 131 | 0.030 |
Why?
|
| Anesthesia | 1 | 1974 | 164 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2001 | 1004 | 0.030 |
Why?
|
| Vincristine | 2 | 1981 | 111 | 0.030 |
Why?
|
| Neoplasms | 2 | 1985 | 2898 | 0.030 |
Why?
|
| Gammaretrovirus | 1 | 1971 | 4 | 0.030 |
Why?
|
| Antigens | 2 | 1970 | 228 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1970 | 261 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 1990 | 19 | 0.020 |
Why?
|
| Moloney murine leukemia virus | 1 | 1970 | 5 | 0.020 |
Why?
|
| Leukemia Virus, Murine | 1 | 1970 | 18 | 0.020 |
Why?
|
| Prednisolone | 1 | 1970 | 41 | 0.020 |
Why?
|
| Cell Biology | 1 | 1970 | 13 | 0.020 |
Why?
|
| Membranes | 1 | 1970 | 36 | 0.020 |
Why?
|
| Cytoplasm | 5 | 1977 | 281 | 0.020 |
Why?
|
| Uridine | 4 | 1974 | 56 | 0.020 |
Why?
|
| Medulloblastoma | 2 | 1981 | 36 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1990 | 121 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1969 | 91 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1971 | 269 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1980 | 989 | 0.020 |
Why?
|
| Lung Neoplasms | 4 | 1983 | 2262 | 0.020 |
Why?
|
| Adolescent | 5 | 2000 | 8981 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1973 | 112 | 0.020 |
Why?
|
| Sarcoma, Experimental | 2 | 1983 | 53 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 1968 | 17 | 0.020 |
Why?
|
| Social Support | 1 | 1990 | 193 | 0.020 |
Why?
|
| Liver | 4 | 1985 | 1230 | 0.020 |
Why?
|
| Cells, Cultured | 5 | 1985 | 2818 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 1990 | 178 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 1990 | 351 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1975 | 268 | 0.020 |
Why?
|
| Antibodies | 1 | 1969 | 350 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1979 | 332 | 0.020 |
Why?
|
| Hypoxanthines | 2 | 1983 | 11 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1990 | 462 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1984 | 131 | 0.010 |
Why?
|
| Hypoxanthine | 1 | 1983 | 4 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1983 | 35 | 0.010 |
Why?
|
| Mitochondria | 3 | 1973 | 535 | 0.010 |
Why?
|
| Inulin | 1 | 1983 | 17 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1983 | 307 | 0.010 |
Why?
|
| Dactinomycin | 2 | 1972 | 36 | 0.010 |
Why?
|
| Tissue Distribution | 2 | 1985 | 290 | 0.010 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1982 | 11 | 0.010 |
Why?
|
| Organizational Culture | 1 | 2002 | 33 | 0.010 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1982 | 32 | 0.010 |
Why?
|
| Creatinine | 1 | 1983 | 338 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1972 | 29 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1983 | 384 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1981 | 19 | 0.010 |
Why?
|
| Meninges | 2 | 1971 | 13 | 0.010 |
Why?
|
| Ribosomes | 2 | 1973 | 111 | 0.010 |
Why?
|
| Probability | 1 | 1981 | 355 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1980 | 32 | 0.010 |
Why?
|
| Hematocrit | 2 | 1990 | 68 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 1982 | 1047 | 0.010 |
Why?
|
| Angiography | 1 | 1981 | 208 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1979 | 25 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1979 | 30 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1982 | 464 | 0.010 |
Why?
|
| Blood | 1 | 1979 | 69 | 0.010 |
Why?
|
| Culture Media | 1 | 1979 | 147 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1981 | 916 | 0.010 |
Why?
|
| Cell Survival | 2 | 1978 | 969 | 0.010 |
Why?
|
| Biological Transport | 1 | 1979 | 396 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1985 | 1056 | 0.010 |
Why?
|
| Kidney Glomerulus | 2 | 1970 | 123 | 0.010 |
Why?
|
| Kidney Tubules | 2 | 1970 | 94 | 0.010 |
Why?
|
| Species Specificity | 2 | 1970 | 678 | 0.010 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 1978 | 3 | 0.010 |
Why?
|
| RNA, Transfer | 2 | 1977 | 151 | 0.010 |
Why?
|
| Clone Cells | 1 | 1978 | 213 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1978 | 9 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1978 | 248 | 0.010 |
Why?
|
| Tetrahydrofolates | 1 | 1977 | 13 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1978 | 121 | 0.010 |
Why?
|
| Choroid Plexus | 1 | 1977 | 14 | 0.010 |
Why?
|
| Methods | 2 | 1985 | 152 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1978 | 82 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1978 | 61 | 0.010 |
Why?
|
| Meningioma | 1 | 1978 | 60 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 1978 | 155 | 0.010 |
Why?
|
| Folic Acid | 1 | 1977 | 60 | 0.010 |
Why?
|
| Adenosine | 3 | 1975 | 225 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1978 | 347 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1977 | 258 | 0.010 |
Why?
|
| Ribonucleases | 2 | 1974 | 92 | 0.010 |
Why?
|
| Fruit | 1 | 1977 | 75 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1985 | 2438 | 0.010 |
Why?
|
| Fetus | 1 | 1977 | 226 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 76 | 0.010 |
Why?
|
| Deoxyadenosines | 2 | 1975 | 23 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1977 | 510 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1978 | 255 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 1981 | 2903 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1977 | 729 | 0.010 |
Why?
|
| Glioma | 1 | 1978 | 285 | 0.010 |
Why?
|
| Bone Marrow | 2 | 1982 | 435 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1974 | 81 | 0.010 |
Why?
|
| Adult | 3 | 1983 | 25648 | 0.010 |
Why?
|
| Reticulocytes | 2 | 1990 | 25 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1974 | 177 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1973 | 51 | 0.010 |
Why?
|
| Formamides | 1 | 1973 | 2 | 0.010 |
Why?
|
| Alkalies | 1 | 1973 | 8 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1973 | 34 | 0.010 |
Why?
|
| Centrifugation, Zonal | 1 | 1972 | 10 | 0.010 |
Why?
|
| Aging | 1 | 1977 | 691 | 0.010 |
Why?
|
| Ethidium | 1 | 1972 | 13 | 0.010 |
Why?
|
| Sucrose | 1 | 1973 | 64 | 0.010 |
Why?
|
| Pancreas | 1 | 1974 | 239 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1973 | 92 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1972 | 55 | 0.010 |
Why?
|
| Acrylamides | 1 | 1972 | 30 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1972 | 181 | 0.010 |
Why?
|
| Pyrazoles | 1 | 1973 | 153 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1973 | 493 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1971 | 76 | 0.010 |
Why?
|
| Lymphatic System | 1 | 1971 | 53 | 0.010 |
Why?
|
| Leukemoid Reaction | 1 | 1970 | 5 | 0.010 |
Why?
|
| DNA Repair | 1 | 1973 | 356 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1985 | 1686 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1973 | 370 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1978 | 1169 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1984 | 245 | 0.010 |
Why?
|
| Cricetinae | 2 | 1984 | 560 | 0.010 |
Why?
|
| Urography | 1 | 1970 | 45 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1970 | 62 | 0.010 |
Why?
|
| Ammonia | 1 | 1970 | 37 | 0.010 |
Why?
|
| Haplorhini | 1 | 1970 | 81 | 0.010 |
Why?
|
| Organ Size | 1 | 1971 | 364 | 0.010 |
Why?
|
| Hemoglobinometry | 1 | 1969 | 9 | 0.010 |
Why?
|
| Polycythemia | 1 | 1969 | 8 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1969 | 23 | 0.010 |
Why?
|
| Fetal Hemoglobin | 1 | 1969 | 14 | 0.010 |
Why?
|
| Twins | 1 | 1970 | 65 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1970 | 54 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1970 | 63 | 0.010 |
Why?
|
| Spleen | 1 | 1971 | 430 | 0.010 |
Why?
|
| Body Weight | 1 | 1971 | 459 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1969 | 23 | 0.010 |
Why?
|
| Birth Weight | 1 | 1969 | 145 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1969 | 13 | 0.010 |
Why?
|
| Peroxidases | 1 | 1969 | 34 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1969 | 44 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1969 | 130 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1970 | 249 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1969 | 111 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1970 | 151 | 0.010 |
Why?
|
| Microscopy | 1 | 1969 | 87 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1969 | 316 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1971 | 533 | 0.000 |
Why?
|
| Aged | 2 | 1982 | 18415 | 0.000 |
Why?
|
| Binding Sites | 1 | 1969 | 1098 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 332 | 0.000 |
Why?
|
| Middle Aged | 2 | 1982 | 25028 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1985 | 121 | 0.000 |
Why?
|
| NADP | 1 | 1985 | 45 | 0.000 |
Why?
|
| Demecolcine | 1 | 1984 | 1 | 0.000 |
Why?
|
| Chickens | 1 | 1985 | 212 | 0.000 |
Why?
|
| Cattle | 1 | 1985 | 376 | 0.000 |
Why?
|
| Cricetulus | 1 | 1984 | 126 | 0.000 |
Why?
|
| Polynucleotides | 2 | 1975 | 17 | 0.000 |
Why?
|
| Cell Fractionation | 2 | 1975 | 71 | 0.000 |
Why?
|
| Rats | 1 | 1970 | 3990 | 0.000 |
Why?
|
| Adenine | 2 | 1975 | 85 | 0.000 |
Why?
|
| Ovary | 1 | 1984 | 258 | 0.000 |
Why?
|
| Pregnancy | 1 | 1970 | 2894 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1982 | 144 | 0.000 |
Why?
|
| Mice, Inbred AKR | 1 | 1982 | 10 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1982 | 34 | 0.000 |
Why?
|
| Mice, Inbred DBA | 1 | 1982 | 148 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1985 | 1169 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1982 | 459 | 0.000 |
Why?
|
| Base Sequence | 1 | 1984 | 2330 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1980 | 102 | 0.000 |
Why?
|
| Protein Binding | 1 | 1982 | 1456 | 0.000 |
Why?
|
| Prognosis | 1 | 1985 | 3679 | 0.000 |
Why?
|
| Lung | 1 | 1984 | 1170 | 0.000 |
Why?
|
| Poly A | 1 | 1977 | 23 | 0.000 |
Why?
|
| Simian virus 40 | 1 | 1977 | 35 | 0.000 |
Why?
|
| Polyomavirus | 1 | 1977 | 16 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1983 | 3640 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1982 | 1195 | 0.000 |
Why?
|
| Poly U | 1 | 1975 | 6 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1975 | 19 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1982 | 3092 | 0.000 |
Why?
|
| Puromycin | 1 | 1973 | 10 | 0.000 |
Why?
|
| Deoxyribonucleases | 1 | 1973 | 27 | 0.000 |
Why?
|
| Priapism | 1 | 1969 | 5 | 0.000 |
Why?
|
| Hypocalcemia | 1 | 1969 | 41 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1969 | 107 | 0.000 |
Why?
|
| Gestational Age | 1 | 1969 | 311 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1969 | 150 | 0.000 |
Why?
|
| Infant, Premature | 1 | 1969 | 290 | 0.000 |
Why?
|
| Sex Factors | 1 | 1969 | 1054 | 0.000 |
Why?
|